Munich-based healthtech startup Calliora has raised $6 million in Pre-Seed funding to build an artificial intelligence platform for hospital financial operations. The round was led by Bertelsmann Healthcare Investments and Swiss venture capital firm redalpine, with angel investors from hospital management and AI research also participating. The company is developing an AI operating layer that connects patient admission, clinical documentation, coding, and reimbursement to reduce revenue leakage for hospitals.
Funding and Investor Backing
The financing gives Calliora early support from backers with experience across the German and European healthcare and AI sectors. Angel investors include Dr. Ulrich Wandschneider, former CEO of Asklepios and Mediclin, as well as Deloitte Global Health Sector Leader Sara Siegel, Peter Sarlin, and AI researcher Frank Hutter of Prior Labs. The capital will be used to continue developing the platform for hospital financial operations and to prepare for stricter audit requirements.
Regulatory Pressure Ahead
German hospitals are facing a tightening audit environment under the Statutory Health Insurance Contribution Rate Stabilization Act. Until the end of 2026, the audit cap for hospital invoices ranges from 5% to 15%, but from 2027 a hospital with more than 35% of audited invoices rejected can face audits of up to 40% of invoices. If the Medical Service rejects more than half, the cap disappears entirely and up to 100% of invoices can be audited.
Measurement Has Already Begun
Hospital audit results from the third quarter of 2026 will set the cap for the first quarter of 2027, meaning hospitals are being judged before the new law formally takes effect. Calliora argues that an error costs least before an invoice exists, because a missing detail takes minutes to add at that stage. In an audit, the same error can trigger a repayment, a penalty surcharge, and hours of work across the hospital, the insurer, and the Medical Service.
An AI Layer over Hospital Cases
Calliora was founded in 2023 by Frederik Träuble and Jonas Wildberger, and it focuses on the point where clinical documentation, coding, audits, and hospital economics meet. The platform is designed to surface a missing diagnosis or missing evidence before an invoice is submitted, and the company says its AI has more than halved the effort required per case. The company processes data only in Germany, with ISO 27001 certification and a BSI C5 cloud security attestation to support GDPR compliance.
Market Context and Competitors
Calliora enters a European market where several startups are using AI to reduce hospital paperwork. Paris-based Parallel raised a US$20 million Series A led by Index Ventures in March 2026, while Health Force raised €4.2 million in Seed funding in September 2026 and Tandem Health raised a US$100 million Series B. Calliora's route is narrower and tied more closely to Germany's audit rules, although the hospitals using its platform remain unnamed.
Early Test in 2027
The company argues that checking cases before invoicing reduces rejections and helps hospitals capture the financial value linked to their care. Investor comments suggest that administrative inefficiency costs the healthcare system billions every year, and that Calliora tackles errors at the source instead of correcting them after the fact. However, every outside voice currently supporting the case is a backer or an adviser, creating an evidence gap that real hospital customers have not yet filled.
The new funding positions Calliora to develop its technology ahead of a regulatory shift that will increase audit exposure for many German hospitals. Its central claim, that early case checking cuts invoice rejections, will meet real audit data when the new caps start to apply in early 2027. If the platform performs as intended, it could give hospital staff back time to focus on care while improving financial sustainability.